semustine has been researched along with medroxyprogesterone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Carbone, PP; Hahn, RG; Horton, J; Marsh, J; Perlia, C; Savlov, ED; Temkin, NR; Wampler, GL | 1 |
| Dorn, W; Gladden, MP; Rankin, EA | 1 |
1 trial(s) available for semustine and medroxyprogesterone
| Article | Year |
|---|---|
Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancer.
Topics: Adenocarcinoma; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Humans; Kidney Neoplasms; Medroxyprogesterone; Neoplasm Metastasis; Nitrosourea Compounds; Prognosis; Semustine; Vinblastine | 1978 |
2 other study(ies) available for semustine and medroxyprogesterone
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Regression of a renal-cell metastatic osseous lesion following treatment.
Topics: Adenocarcinoma; Bone Neoplasms; Humans; Humerus; Kidney Neoplasms; Male; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Nephrectomy; Semustine; Vinblastine | 1975 |